• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质性肺疾病中的咳嗽

Cough in interstitial lung disease.

作者信息

Garner Justin, George Peter M, Renzoni Elisabetta

机构信息

Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Trust, United Kingdom.

Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Trust, United Kingdom; National Heart and Lung Institute, Imperial College London, United Kingdom.

出版信息

Pulm Pharmacol Ther. 2015 Dec;35:122-8. doi: 10.1016/j.pupt.2015.10.009. Epub 2015 Nov 3.

DOI:10.1016/j.pupt.2015.10.009
PMID:26545874
Abstract

Cough in the context of interstitial lung disease (ILD) has not been the focus of many studies. However, chronic cough has a major impact on quality of life in a significant proportion of patients with ILD. For the purpose of this review, we have chosen to highlight some of the more frequently encountered diffuse lung diseases including idiopathic pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis and systemic sclerosis associated ILD. Many of the underlying mechanisms remain speculative and further research is now required to elucidate the complex pathways involved in the pathogenesis of chronic cough in ILD. This will hopefully pave the way for the identification of new therapeutic agents to alleviate this distressing and often intractable symptom.

摘要

间质性肺疾病(ILD)中的咳嗽尚未成为众多研究的焦点。然而,慢性咳嗽对相当一部分ILD患者的生活质量有重大影响。出于本综述的目的,我们选择重点介绍一些较常见的弥漫性肺疾病,包括特发性肺纤维化、结节病、过敏性肺炎以及与系统性硬化症相关的ILD。许多潜在机制仍属推测,目前需要进一步研究以阐明ILD中慢性咳嗽发病机制所涉及的复杂途径。这有望为识别新的治疗药物以缓解这种令人痛苦且往往难以治疗的症状铺平道路。

相似文献

1
Cough in interstitial lung disease.间质性肺疾病中的咳嗽
Pulm Pharmacol Ther. 2015 Dec;35:122-8. doi: 10.1016/j.pupt.2015.10.009. Epub 2015 Nov 3.
2
Mechanisms and management of cough in interstitial lung disease.间质性肺疾病咳嗽的机制与管理。
Expert Rev Respir Med. 2023 Dec;17(12):1177-1190. doi: 10.1080/17476348.2023.2299751. Epub 2023 Dec 30.
3
Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease.患有间质性肺病的进行性系统性硬化症患者咳嗽反射敏感性增加。
Eur Respir J. 1998 Mar;11(3):702-5.
4
Chronic cough in adults with interstitial lung disease.成人间质性肺疾病中的慢性咳嗽。
Curr Opin Pulm Med. 2005 Sep;11(5):412-6. doi: 10.1097/01.mcp.0000174249.07762.37.
5
Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.与其他纤维性间质性肺疾病相比,系统性硬化症相关间质性肺疾病患者的咳嗽症状较少见且程度较轻。
Respirology. 2017 Nov;22(8):1592-1597. doi: 10.1111/resp.13084. Epub 2017 May 23.
6
Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II.硬皮病相关间质性肺病患者咳嗽及咳嗽特异性生活质量改善:硬皮病肺部研究II的结果
Chest. 2017 Apr;151(4):813-820. doi: 10.1016/j.chest.2016.11.052. Epub 2016 Dec 22.
7
Clinical significance of self-reported cough intensity and frequency in patients with interstitial lung disease: a cross-sectional study.特发性肺纤维化患者自我报告咳嗽强度和频率的临床意义:一项横断面研究。
BMC Pulm Med. 2019 Dec 16;19(1):247. doi: 10.1186/s12890-019-1012-6.
8
Exploring the Potential of a P2X3 Receptor Antagonist: Gefapixant in the Management of Persistent Cough Associated with Interstitial Lung Disease.探索P2X3受体拮抗剂吉法匹酯在治疗与间质性肺病相关的持续性咳嗽中的潜力。
Medicina (Kaunas). 2025 May 14;61(5):892. doi: 10.3390/medicina61050892.
9
Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report.特发性肺纤维化相关咳嗽的治疗:CHEST 指南和专家小组报告。
Chest. 2018 Oct;154(4):904-917. doi: 10.1016/j.chest.2018.06.038. Epub 2018 Jul 20.
10
What causes cough in pulmonary fibrosis, and how should we treat it?肺纤维化中咳嗽的病因是什么,我们应如何治疗?
Curr Opin Pulm Med. 2024 Sep 1;30(5):523-529. doi: 10.1097/MCP.0000000000001087. Epub 2024 Jun 24.

引用本文的文献

1
Exploring the Potential of a P2X3 Receptor Antagonist: Gefapixant in the Management of Persistent Cough Associated with Interstitial Lung Disease.探索P2X3受体拮抗剂吉法匹酯在治疗与间质性肺病相关的持续性咳嗽中的潜力。
Medicina (Kaunas). 2025 May 14;61(5):892. doi: 10.3390/medicina61050892.
2
Updates on the Prevalence, Quality of Life, and Management of Chronic Cough in Interstitial Lung Diseases.间质性肺疾病中慢性咳嗽的患病率、生活质量及管理的最新进展
Diagnostics (Basel). 2025 Apr 29;15(9):1139. doi: 10.3390/diagnostics15091139.
3
"Nebulized lidocaine for intractable cough in hospice care: a comprehensive review of efficacy, safety, and future perspectives".
雾化利多卡因用于临终关怀中难治性咳嗽:疗效、安全性及未来展望的全面综述
BMC Palliat Care. 2025 Apr 30;24(1):123. doi: 10.1186/s12904-025-01752-z.
4
Cough in chronic lung disease: a state of the art review.慢性肺病中的咳嗽:最新综述
J Thorac Dis. 2023 Oct 31;15(10):5823-5843. doi: 10.21037/jtd-22-1776. Epub 2023 Sep 21.
5
Study of nasal mucosa histopathological changes in patients with hypersensitivity pneumonitis.变应性肺炎患者鼻黏膜组织病理学变化的研究。
Sci Rep. 2023 May 31;13(1):8868. doi: 10.1038/s41598-023-35871-5.
6
Management of cough in patients with idiopathic interstitial lung diseases in primary care.基层医疗中特发性间质性肺疾病患者咳嗽的管理。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221089319. doi: 10.1177/14799731221089319.
7
Antitussive Effect of a Chest Band in Patients with Interstitial Lung Disease: The Preliminary Results from a Pre-post Intervention Study.胸部带对间质性肺疾病患者镇咳作用的初步研究结果:一项干预前后研究的初步结果。
Intern Med. 2021;60(23):3701-3707. doi: 10.2169/internalmedicine.6716-20. Epub 2021 Dec 1.
8
Clinical significance of self-reported cough intensity and frequency in patients with interstitial lung disease: a cross-sectional study.特发性肺纤维化患者自我报告咳嗽强度和频率的临床意义:一项横断面研究。
BMC Pulm Med. 2019 Dec 16;19(1):247. doi: 10.1186/s12890-019-1012-6.